Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 2
2005 3
2006 10
2007 15
2008 14
2009 22
2010 26
2011 14
2012 11
2013 17
2014 18
2015 10
2016 14
2017 14
2018 16
2019 36
2020 34
Text availability
Article attribute
Article type
Publication date

Search Results

229 results
Results by year
Filters applied: . Clear all
Page 1
Did you mean qiaojunhe (23 results)?
Stress granule: A promising target for cancer treatment.
Gao X, Jiang L, Gong Y, Chen X, Ying M, Zhu H, He Q, Yang B, Cao J. Gao X, et al. Among authors: he q. Br J Pharmacol. 2019 Dec;176(23):4421-4433. doi: 10.1111/bph.14790. Epub 2019 Nov 8. Br J Pharmacol. 2019. PMID: 31301065 Review.
Single-Cell Transcriptomics Uncovers Glial Progenitor Diversity and Cell Fate Determinants during Development and Gliomagenesis.
Weng Q, Wang J, Wang J, He D, Cheng Z, Zhang F, Verma R, Xu L, Dong X, Liao Y, He X, Potter A, Zhang L, Zhao C, Xin M, Zhou Q, Aronow BJ, Blackshear PJ, Rich JN, He Q, Zhou W, SuvĂ  ML, Waclaw RR, Potter SS, Yu G, Lu QR. Weng Q, et al. Among authors: he q. Cell Stem Cell. 2019 May 2;24(5):707-723.e8. doi: 10.1016/j.stem.2019.03.006. Epub 2019 Apr 11. Cell Stem Cell. 2019. PMID: 30982771 Free PMC article.
Identification of PRDX6 as a regulator of ferroptosis.
Lu B, Chen XB, Hong YC, Zhu H, He QJ, Yang B, Ying MD, Cao J. Lu B, et al. Acta Pharmacol Sin. 2019 Oct;40(10):1334-1342. doi: 10.1038/s41401-019-0233-9. Epub 2019 Apr 29. Acta Pharmacol Sin. 2019. PMID: 31036877
LncRNA-MM2P Identified as a Modulator of Macrophage M2 Polarization.
Cao J, Dong R, Jiang L, Gong Y, Yuan M, You J, Meng W, Chen Z, Zhang N, Weng Q, Zhu H, He Q, Ying M, Yang B. Cao J, et al. Among authors: he q. Cancer Immunol Res. 2019 Feb;7(2):292-305. doi: 10.1158/2326-6066.CIR-18-0145. Epub 2018 Nov 20. Cancer Immunol Res. 2019. PMID: 30459152 Free article.
Molecular basis for class side effects associated with PI3K/AKT/mTOR pathway inhibitors.
Zhang Y, Yan H, Xu Z, Yang B, Luo P, He Q. Zhang Y, et al. Among authors: he q. Expert Opin Drug Metab Toxicol. 2019 Sep;15(9):767-774. doi: 10.1080/17425255.2019.1663169. Epub 2019 Sep 3. Expert Opin Drug Metab Toxicol. 2019. PMID: 31478386 Review.
Ubiquitin-dependent degradation of CDK2 drives the therapeutic differentiation of AML by targeting PRDX2.
Ying M, Shao X, Jing H, Liu Y, Qi X, Cao J, Chen Y, Xiang S, Song H, Hu R, Wei G, Yang B, He Q. Ying M, et al. Among authors: he q. Blood. 2018 Jun 14;131(24):2698-2711. doi: 10.1182/blood-2017-10-813139. Epub 2018 May 2. Blood. 2018. PMID: 29720484
Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.
Wang J, Wang J, Wang J, Yang B, Weng Q, He Q. Wang J, et al. Among authors: he q. Front Pharmacol. 2019 Mar 22;10:286. doi: 10.3389/fphar.2019.00286. eCollection 2019. Front Pharmacol. 2019. PMID: 30967783 Free PMC article. Review.
MDM2 promotes epithelial-mesenchymal transition and metastasis of ovarian cancer SKOV3 cells.
Chen Y, Wang DD, Wu YP, Su D, Zhou TY, Gai RH, Fu YY, Zheng L, He QJ, Zhu H, Yang B. Chen Y, et al. Br J Cancer. 2017 Oct 10;117(8):1192-1201. doi: 10.1038/bjc.2017.265. Epub 2017 Aug 17. Br J Cancer. 2017. PMID: 28817834 Free PMC article.
Gefitinib inhibits M2-like polarization of tumor-associated macrophages in Lewis lung cancer by targeting the STAT6 signaling pathway.
Tariq M, Zhang JQ, Liang GK, He QJ, Ding L, Yang B. Tariq M, et al. Acta Pharmacol Sin. 2017 Nov;38(11):1501-1511. doi: 10.1038/aps.2017.124. Epub 2017 Oct 12. Acta Pharmacol Sin. 2017. PMID: 29022575 Free PMC article.
229 results
Jump to page